EUVIMED · CrossrefZeitschrift
Alzheimer's Research & Therapy
ISSN 1758-9193 · Springer Science and Business Media LLC
Neueste Artikel
The E79 Alzheimer index: a spectral multimodal biomarker tool for stratification of rapid MCI-to-AD conversion
CSF colony-stimulating factor 1 and its receptor mediate the association of amyloid-β with tau pathology and predict Alzheimer’s disease progression: a longitudinal ADNI study
The EPND cohort: study design and CSF proteomics across Alzheimer’s disease, dementia with Lewy bodies, and Parkinson’s disease
Olfactory decline in aging and preceding conversion to mild cognitive impairment: longitudinal trajectories and associations with cognitive decline and postmortem neuropathology
Real-world study of donanemab in Alzheimer’s disease: a six-center Chinese cohort
Slow-wave sleep across the Alzheimer’s disease continuum: cognitive trajectories and sex differences
A pain in the Aß: a typographical plea to the amyloid community
Incidence and risk of Alzheimer’s disease in individuals with type 2 diabetes: a systematic review and meta-analysis
Computerised cognitive training combined with nutritional counseling in mild cognitive impairment - results of a 2 × 2 factorial randomized controlled trial (BrainFit-nutrition study)
Correction: Explaining the association between social and lifestyle factors and cognitive functions: a pathway analysis in the Memento cohort
Cognitive impairment, medial temporal lobe changes, and fluid biomarkers of Alzheimer’s disease and neurodegeneration following herpes simplex virus type 1 encephalitis
Initial development of the lewy body dementia – domain rating scale: a disease-specific outcome measure
Brain-derived extracellular vesicle profiling in Down syndrome-associated Alzheimer’s disease
Effect of high-risk SORL1 variants on clinical presentation in symptomatic Alzheimer’s disease
Differences in Alzheimer’s disease biomarkers between African American and White participants across cerebrospinal fluid and plasma: a systematic review and meta-analysis
A prospective observational study measuring the stability of plasma pTau181 using the Elecsys Phospho-Tau (181P) plasma immunoassay for early detection of Alzheimer’s disease
Network connectivity and amyloid-β align with tau in atypical Alzheimer disease subtypes
Live brain biopsy during CSF shunt surgery for precision diagnostics and multi-omic research
Data-driven mapping of known and novel fluid biomarker progression profiles in genetic frontotemporal lobar degeneration
A CSF NPTX2-based residual metric captures prognostic heterogeneity within a proposed compensatory framework in prodromal Alzheimer’s disease
MemTrax as a scalable digital triage tool for mild cognitive impairment screening: primary validation in Alzheimer’s disease and exploratory analysis in Parkinson’s disease
Neuropathological and vascular determinants of cerebral amyloid angiopathy risk: evidence from the NACC cohort
Virtual brain and electroencephalography explain the variance of memory alterations in mild cognitive impairment
Longitudinal plasma p-tau217 as a marker for tracking progression and predicting cognitive decline in Alzheimer’s disease
Plasma p-tau217, p-tau181, and Aβ42 predict amyloid PET positivity in cognitively unimpaired adults
Plasma extracellular vesicle proteins biomarker for cerebral small vessel disease related cognitive impairment
Proteomic analysis in Alzheimer’s disease and other dementias: a focus on sex-specific differences
Women’s reproductive life patterns, intrinsic capacity, and the risk of all-cause and cause-specific dementia: a prospective cohort study
Genetic drivers of progression in Alzheimer’s disease are distinct from disease risk
Pathways to resilience: relationships between cognitive reserve, psychological debt, and Alzheimer’s disease biomarkers
EUVIMED